Erythema - 159 Studies Found Completed : Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) : Lupus Erythematosus, Systemic : 2003-10-24 : Drug: Placebo Placebo IV plus Not yet recruiting : A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus : Lupus Erythematosus, Systemic : 2016-09-29 : Drug: JNJ-56022473 Subjects wi Active, not recruiting : A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus : Lupus Erythematosus, Systemic : 2015-04-29 : Biological: ALX-0061 Biological: Placebo Completed : A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Active Systemic Lupus Erythematosus (SLE) : Lupus Erythematosus, Systemic : 2016-11-01 : Drug: Repository corticotropin injection Active, not recruiting : A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus : Lupus Erythematosus, Systemic : 2015-07-17 : Drug: IPP-201101 Other Name: L Enrolling by invitation : An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults : Lupus Erythematosus, Systemic : 2012-12-17 : Biological: MEDI-546 MEDI-546, IV q4wks for 104 weeks Suspended : Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine : Systemic Lupus Erythematosus : 2008-10-17 : Drug: N-acetylcysteine Capsule Active, not recruiting : Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients : Systemic Lupus Erythematosus : 2014-11-18 : Drug: MT-1303 Low dose Drug: MT-1303 High
